Unknown

Dataset Information

0

The association of phosphoinositide 3-kinase enhancer A with hepatic insulin receptor enhances its kinase activity.


ABSTRACT: Dysfunction of hepatic insulin receptor tyrosine kinase (IRTK) causes the development of type 2 diabetes. However, the molecular mechanism regulating IRTK activity in the liver remains poorly understood. Here, we show that phosphoinositide 3-kinase enhancer A (PIKE-A) is a new insulin-dependent enhancer of hepatic IRTK. Liver-specific Pike-knockout (LPKO) mice display glucose intolerance with impaired hepatic insulin sensitivity. Specifically, insulin-provoked phosphoinositide 3-kinase/Akt signalling is diminished in the liver of LPKO mice, leading to the failure of insulin-suppressed gluconeogenesis and hyperglycaemia. Thus, hepatic PIKE-A has a key role in mediating insulin signal transduction and regulating glucose homeostasis in the liver.

SUBMITTER: Chan CB 

PROVIDER: S-EPMC3147257 | BioStudies | 2011-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC2844836 | BioStudies
1000-01-01 | S-EPMC5482076 | BioStudies
2020-01-01 | S-EPMC7533871 | BioStudies
2014-01-01 | S-EPMC4028201 | BioStudies
1000-01-01 | S-EPMC3918755 | BioStudies
2011-01-01 | S-EPMC3199380 | BioStudies
2017-01-01 | S-EPMC5552418 | BioStudies
2005-01-01 | S-EPMC1134738 | BioStudies
1000-01-01 | S-EPMC4703802 | BioStudies
2000-01-01 | S-EPMC1221333 | BioStudies